REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Endomed-Ikar Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Endomed-Ikar Sp. z o.o. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Endomed-Ikar Sp. z o.o. is an enterprise in Poland, with the main office in Bydgoszcz. It operates in the Ambulatory Health Care Services industry. The company was established on September 08, 2009. Endomed-Ikar Sp. z o.o. currently employs 2 (2014) people. There was a net sales revenue increase of 53.68% reported in Endomed-Ikar Sp. z o.o.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 184.3%. In, 2023, the company’s net profit margin increased by 3.56%.

Headquarters
Ul. Szubinska 32
Bydgoszcz; Kujawsko-Pomorskie; Postal Code: 85-915

Contact Details: Purchase the Endomed-Ikar Sp. z o.o. report to view the information.

Website: http://www.endomed­ikar.bydgoszcz.pl

Basic Information
Total Employees:
Purchase the Endomed-Ikar Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Endomed-Ikar Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Endomed-Ikar Sp. z o.o. report to view the information.
Incorporation Date:
September 08, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Endomed-Ikar Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
53.68%▲
Total operating revenue
53.66%▲
Operating profit (EBIT)
72.78%▲
EBITDA
84.2%▲
Net Profit (Loss) for the Period
72.46%▲
Total assets
184.3%▲
Total equity
172.03%▲
Operating Profit Margin (ROS)
3.62%▲
Net Profit Margin
3.56%▲
Return on Equity (ROE)
-36.52%▼
Quick Ratio
-1.17%▼
Cash Ratio
-0.2%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo